NYSE$VTR
Ventas Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Ventas' diversified portfolio showed resilience, driven by growth in life science, medical office, and triple-net portfolios, and sustained demand in senior housing despite COVID-19 and labor market challenges.
Ventas reported strong Q3 2021 results with growth in life science, medical office, and healthcare triple net portfolios. Senior housing communities saw sustained demand and revenue growth, with average occupancy up 230 basis points sequentially. The company completed or announced $3.7 billion in strategic investments, including the acquisition of New Senior and a life science project anchored by University of California, Davis. Ventas expects a robust recovery in senior housing and aims to capture benefits from completed investments and external growth opportunities.
- Ventas' high-quality diversified portfolio demonstrated strength in the third quarter of 2021 despite the challenges of COVID-19 and a tight labor market.
- Average SHOP occupancy grew 230 basis points sequentially and eight consecutive months of occupancy growth through October.
- Completed and announced strategic investments of $3.7 billion in 2021, including acquisition of New Senior and UC Davis life science project.
- Expects a robust recovery in senior housing as we also capture the benefits of our completed investments and execute on our external growth opportunities
Headline financials
Revenue & EPS history
Ventas · Revenue · Quarterly
$976M
Revenue by segment
Ventas · $587M total across 3 segments · Q3 2021
- Resident fees and services$558M+3.1%95.0%
- Income from loans and investments$28.7M+53.9%4.9%
- Interest and other income$417K-27.1%0.1%
Forward guidance
The Company currently expects to report fourth quarter 2021 Net Income (Loss) Attributable to Common Stockholders, Nareit FFO and Normalized FFO within the following per share ranges:
Tailwinds
- Average occupancy for fourth quarter 2021 in the same-store SHOP business is expected to increase 80 to 120 basis points sequentially, reflecting continued demand exceeding pre-pandemic levels tempered by typical seasonal trends.
- Revenue for the same-store SHOP business is expected to grow in the fourth quarter as a result of occupancy increases.
- Stable sequential performance is expected in the Office and NNN segments.
- Receipt of a $13 million fee related to the previously announced acquisition of Kindred Healthcare.
- The Company continues to expect to receive approximately $1.0 billion in proceeds from asset sales and loan repayments in 2021 principally in senior housing, medical office and loan investments with proceeds used to reduce near-term indebtedness.
Headwinds
- Approximately stable NOI is expected in the Company’s sequential same-store SHOP business in the fourth quarter. At the mid-point of the range, revenue growth is assumed to be offset by increasing operating costs, notably including continued elevated labor costs.
- We have assumed that no HHS Grants will be received by the Company in the fourth quarter.
- The guidance assumes no material changes in the impact of COVID-19 on our business.
- The trajectory and future impact of the COVID-19 pandemic, including the impact of the Delta or any other variant, remain highly uncertain and may change rapidly.
- Significant changes or impacts of the pandemic are excluded from our guidance.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
+0.6%
Avg return
Earnings day
+1.1%
Avg return
5 days after
+2.3%
Avg return
30 days after
58%
42 / 73 earnings
Positive
+13.9%
Q3 2020
Best reaction
-10.8%
Q3 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.8% | +3.9% | +1.7% | |
| Q4 2025 | +3.4% | +7.3% | +6.3% | |
| Q3 2025 | +6.8% | +7.4% | +15.5% | |
| Q2 2025 | +0.5% | +2.0% | +1.3% | |
| Q1 2025 | -6.5% | -6.1% | -8.3% | |
| Q4 2024 | +8.3% | +11.4% | +11.6% | |
| Q3 2024 | -0.8% | -2.5% | -3.0% | |
| Q2 2024 | +3.6% | +5.0% | +14.1% | |
| Q1 2024 | +4.4% | +6.3% | +13.5% | |
| Q4 2023 | -0.6% | -1.6% | -4.5% | |
| Q3 2023 | +3.0% | +2.3% | +9.3% | |
| Q2 2023 | -7.3% | -6.2% | -11.1% | |
| Q1 2023 | -2.1% | -2.8% | -3.1% | |
| Q4 2022 | -1.7% | -2.0% | -13.9% | |
| Q3 2022 | +5.7% | +13.0% | +23.7% | |
| Q2 2022 | -5.1% | -1.9% | -8.2% | |
| Q1 2022 | -1.4% | -8.9% | -2.7% | |
| Q4 2021 | +1.0% | +0.9% | +13.4% | |
| Q3 2021 | -0.5% | +3.7% | -10.7% | |
| Q2 2021 | -4.3% | -5.1% | -6.1% | |
| Q1 2021 | +1.7% | -3.4% | +5.1% | |
| Q4 2020 | +3.5% | +7.9% | +7.6% | |
| Q3 2020 | +13.9% | +17.8% | +20.3% | |
| Q2 2020 | +7.8% | +4.0% | +12.8% | |
| Q1 2020 | +7.2% | -1.1% | +59.8% | |
| Q4 2019 | +6.5% | +1.1% | -63.4% | |
| Q3 2019 | -10.8% | -10.4% | -20.8% | |
| Q2 2019 | +0.1% | -0.3% | +6.7% | |
| Q1 2019 | +0.7% | +2.8% | +10.9% | |
| Q4 2018 | -1.1% | -0.4% | -3.8% | |
| Q3 2018 | +0.6% | +2.0% | +8.0% | |
| Q2 2018 | -3.3% | -0.9% | +2.4% | |
| Q1 2018 | +8.3% | +10.3% | +13.0% | |
| Q4 2017 | -0.9% | -2.6% | -2.4% | |
| Q3 2017 | +3.5% | +3.2% | +5.9% | |
| Q2 2017 | -0.1% | -2.1% | +0.7% | |
| Q1 2017 | -0.2% | -2.1% | +3.8% | |
| Q4 2016 | +1.6% | -0.2% | -2.1% | |
| Q3 2016 | +2.0% | -4.8% | -9.3% | |
| Q2 2016 | +2.7% | -1.1% | -3.2% | |
| Q1 2016 | +0.6% | — | — | |
| Q4 2015 | +2.1% | — | — | |
| Q3 2015 | -5.7% | — | — | |
| Q2 2015 | +3.8% | — | — | |
| Q1 2015 | -1.0% | — | — | |
| Q4 2014 | -0.7% | — | — | |
| Q3 2014 | -0.6% | — | — | |
| Q2 2014 | -0.3% | — | — | |
| Q1 2014 | +2.2% | — | — | |
| Q4 2013 | -1.9% | — | — | |
| Q3 2013 | +0.9% | — | — | |
| Q2 2013 | -1.1% | — | — | |
| Q1 2013 | +0.5% | — | — | |
| Q4 2012 | +2.3% | — | — | |
| Q3 2012 | +0.4% | — | — | |
| Q2 2012 | +2.2% | — | — | |
| Q1 2012 | +0.1% | — | — | |
| Q4 2011 | +1.1% | — | — | |
| Q3 2011 | +0.9% | — | — | |
| Q2 2011 | -9.3% | — | — | |
| Q1 2011 | -1.7% | — | — | |
| Q4 2010 | -6.2% | — | — | |
| Q3 2010 | -0.5% | — | — | |
| Q2 2010 | +4.0% | — | — | |
| Q1 2009 | -0.8% | — | — | |
| Q1 2010 | -1.6% | — | — | |
| Q4 2007 | +0.2% | — | — | |
| Q4 2009 | +0.2% | — | — | |
| Q3 2008 | -2.1% | — | — | |
| Q3 2009 | -2.1% | — | — | |
| Q2 2008 | +1.7% | — | — | |
| Q2 2009 | +1.7% | — | — | |
| Q4 2008 | +1.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro